Keyphrases
Ascorbic Acid
100%
Prostate Cancer Patients
100%
Castration-resistant Prostate Cancer
50%
Phase II Trial
50%
Early Pregnancy
50%
Advanced Prostate Cancer
50%
National Cohort Study
50%
Diclofenac
50%
Risk of Miscarriage
50%
Treatment Efficacy
50%
Pharmacokinetic Evaluation
50%
Androgen Deprivation Therapy
50%
Misoprostol
50%
High Dose
50%
Treatment Duration
37%
Miscarriage
33%
Prostate Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ascorbic Acid
100%
Castration Resistant Prostate Cancer
50%
Prostate Cancer
50%
Placebo
50%
Phase II Trials
50%
Pharmacokinetic
50%
Spontaneous Abortion
50%
Trimethoprim
50%
Elimination
50%
Folic Acid
50%
Cohort Study
50%
Prostate Specific Antigen
25%
Adverse Event
18%
Medicine and Dentistry
Diclofenac Plus Misoprostol
50%
Infusion
50%
Castration Resistant Prostate Cancer
50%
Ascorbic Acid
50%
Androgen Deprivation Therapy
50%
Prostate Cancer
50%
Phase II Trials
50%
Arm
50%
Prostate Specific Antigen
25%
Side Effect
25%
